Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Epimode Pharma AB
AB
Active
Org 5591873293
Economic activity was not specified by tax authority
·
NACE 0000
Est. 2018 · 7 years old
0 ansatte
Overvåg
Share
Sverige
/
Virksomheder
/
Economic activity was not specified by tax authority
/
Epimode Pharma AB
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Regnskaber
Revenue
SEK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
—
−6
—
—
−8
Depreciation & amort.
−0
—
—
—
−1
EBIT
0
−6
0
0
−9
Net financials
—
—
—
—
—
Profit before tax
0
−6
0
0
−9
Tax
−0
—
—
—
—
Net profit
0
−6
0
0
−9
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
50
50
50
50
192
Equity
50
44
44
44
35
Long-term debt
0
—
—
—
—
Short-term debt
0
6
6
6
157
Total debt
—
6
6
6
157
Financial ratios
5-year trend
EBITDA-margin
-408000.0%
Denne virksomhed
15.8%
Markedsmedian
2582378% under markedet
2021
2025
Soliditetsgrad
18.2%
Denne virksomhed
38.2%
Markedsmedian
52% under markedet
2021
2025
Egenkapitalforrentning
-25.4%
Denne virksomhed
18.4%
Markedsmedian
238% under markedet
2021
2025
Nettoresultatgrad
-442700.0%
Denne virksomhed
8.1%
Markedsmedian
5465532% under markedet
2021
2025
Aktivomsætning
0.00×
Denne virksomhed
1.12×
Markedsmedian
100% under markedet
2021
2025
Gæld/egenkapital
4.49×
Denne virksomhed
0.62×
Markedsmedian
624% over markedet
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Mere om Epimode Pharma AB
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Personer & ejerskab →
Ledelse, bestyrelse og ejerfordeling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk
